News
![Gaming und Metaverse zieht nicht nur Spieler anhttp://www.flickr.com/photos/26137033@N04/2510041943/sizes/m/in/photostream/: All rights reserved by Techreef](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBcXdCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--888d08c604372321f074c93b1f405365eb0a80ac/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Microsoft.jpg?locale=us)
Gaming und Metaverse zieht nicht nur Spieler an
Es mehren sich die Anzeichen für eine Übernahme von Activision Blizzard durch Microsoft. Bisher stand dem unter anderem die US-Kartellbehörde im Weg. Sie ließ nichts unversucht, die 69 Milliarden
![Gaming und Metaverse zieht nicht nur Spieler anhttp://www.flickr.com/photos/26137033@N04/2510041943/sizes/m/in/photostream/: All rights reserved by Techreef](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBcXdCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--888d08c604372321f074c93b1f405365eb0a80ac/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Microsoft.jpg?locale=us)
Gaming und Metaverse zieht nicht nur Spieler an
Es mehren sich die Anzeichen für eine Übernahme von Activision Blizzard durch Microsoft. Bisher stand dem unter anderem die US-Kartellbehörde im Weg. Sie ließ nichts unversucht, die 69 Milliarden
![Gaming und Metaverse zieht nicht nur Spieler anhttp://www.flickr.com/photos/26137033@N04/2510041943/sizes/m/in/photostream/: All rights reserved by Techreef](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBcXdCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--888d08c604372321f074c93b1f405365eb0a80ac/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Microsoft.jpg?locale=us)
Gaming und Metaverse zieht nicht nur Spieler an
Es mehren sich die Anzeichen für eine Übernahme von Activision Blizzard durch Microsoft. Bisher stand dem unter anderem die US-Kartellbehörde im Weg. Sie ließ nichts unversucht, die 69 Milliarden
![Gaming und Metaverse zieht nicht nur Spieler anhttp://www.flickr.com/photos/26137033@N04/2510041943/sizes/m/in/photostream/: All rights reserved by Techreef](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBcXdCIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--888d08c604372321f074c93b1f405365eb0a80ac/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Microsoft.jpg?locale=us)
Gaming und Metaverse zieht nicht nur Spieler an
Es mehren sich die Anzeichen für eine Übernahme von Activision Blizzard durch Microsoft. Bisher stand dem unter anderem die US-Kartellbehörde im Weg. Sie ließ nichts unversucht, die 69 Milliarden
![Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung anhttp://developer.download.nvidia.com/compute/cuda/4_2/rel/toolkit/docs/online/nvidia_logo.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12158/nvidia_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBa1FDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--2ecc072f456c94ff8fd197809e0569e0ee6c8d67/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/nvidia_logo.jpg?locale=us)
Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung an
Unternehmen arbeiten gemeinsam an Software für Biotech- und Pharmaunternehmen, um schneller bessere Behandlungen für Patienten zu entwickeln
SALT LAKE CITY, TORONTO und MONTRÉAL, July 13, 2023
![Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung anhttp://developer.download.nvidia.com/compute/cuda/4_2/rel/toolkit/docs/online/nvidia_logo.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12158/nvidia_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBa1FDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--2ecc072f456c94ff8fd197809e0569e0ee6c8d67/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/nvidia_logo.jpg?locale=us)
Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung an
Unternehmen arbeiten gemeinsam an Software für Biotech- und Pharmaunternehmen, um schneller bessere Behandlungen für Patienten zu entwickeln
SALT LAKE CITY, TORONTO und MONTRÉAL, July 13, 2023
![Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung anhttp://developer.download.nvidia.com/compute/cuda/4_2/rel/toolkit/docs/online/nvidia_logo.jpg: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12158/nvidia_logo.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBa1FDIiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--2ecc072f456c94ff8fd197809e0569e0ee6c8d67/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/nvidia_logo.jpg?locale=us)
Recursion kündigt Zusammenarbeit und Investition in Höhe von 50 Millionen USD von NVIDIA zur Beschleunigung bahnbrechender Modelle für die KI-gestützte Wirkstoffforschung an
Unternehmen arbeiten gemeinsam an Software für Biotech- und Pharmaunternehmen, um schneller bessere Behandlungen für Patienten zu entwickeln
SALT LAKE CITY, TORONTO und MONTRÉAL, July 13, 2023
![PayPal's Comeback An Undervalued Investment Opportunity: https://www.marketbeat.com/logos/articles/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNmxMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--11d8868c5b518de99cf91a09e490d09bab251f1a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg?locale=us)
PayPal's Comeback An Undervalued Investment Opportunity
PayPal (NASDAQ: PYPL) has underperformed the overall market this year, with the stock down 2.72% YTD. However, the fintech giant is gaining attention after shares have soared almost 10% in the
![PayPal's Comeback An Undervalued Investment Opportunity: https://www.marketbeat.com/logos/articles/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNmxMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--11d8868c5b518de99cf91a09e490d09bab251f1a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg?locale=us)
PayPal's Comeback An Undervalued Investment Opportunity
PayPal (NASDAQ: PYPL) has underperformed the overall market this year, with the stock down 2.72% YTD. However, the fintech giant is gaining attention after shares have soared almost 10% in the
![PayPal's Comeback An Undervalued Investment Opportunity: https://www.marketbeat.com/logos/articles/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNmxMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--11d8868c5b518de99cf91a09e490d09bab251f1a/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711135746_paypals-comeback-and-undervalued-investment-opport.jpg?locale=us)
PayPal's Comeback An Undervalued Investment Opportunity
PayPal (NASDAQ: PYPL) has underperformed the overall market this year, with the stock down 2.72% YTD. However, the fintech giant is gaining attention after shares have soared almost 10% in the
![Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023: https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnBMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6e8d7ca5055d5120cc950f7320f09e498bac50bd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg?locale=us)
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023
Some of the best performers of 2023 sold off on news that the Nasdaq 100 index was conducting a special rebalancing later this month.
Nasdaq announced the rebalance on Friday, July 7, after the
![Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023: https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnBMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6e8d7ca5055d5120cc950f7320f09e498bac50bd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg?locale=us)
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023
Some of the best performers of 2023 sold off on news that the Nasdaq 100 index was conducting a special rebalancing later this month.
Nasdaq announced the rebalance on Friday, July 7, after the
![Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023: https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnBMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6e8d7ca5055d5120cc950f7320f09e498bac50bd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg?locale=us)
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023
Some of the best performers of 2023 sold off on news that the Nasdaq 100 index was conducting a special rebalancing later this month.
Nasdaq announced the rebalance on Friday, July 7, after the
![Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023: https://www.marketbeat.com/logos/articles/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNnBMYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--6e8d7ca5055d5120cc950f7320f09e498bac50bd/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230711134248_nasdaq-100-index-shake-up-rattles-high-flying-stoc.jpg?locale=us)
Nasdaq 100 Index Shake-Up Rattles High-Flying Stocks of 2023
Some of the best performers of 2023 sold off on news that the Nasdaq 100 index was conducting a special rebalancing later this month.
Nasdaq announced the rebalance on Friday, July 7, after the
![Fortinet Positioned For Growth In AI-Based Cybersecurity Boom: https://www.valuewalk.com/wp-content/uploads/2023/05/Cyber-Insurance-300x150.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekVSYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3d00e9a4f8aa52a356ad62f43ff8ca7aa24877d7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Cyber-Insurance-300x150.jpeg?locale=us)
Fortinet Positioned For Growth In AI-Based Cybersecurity Boom
Key Points
- Cybersecurity spending on enterprise information security is projected to grow rapidly, driven by factors such as AI.
- Fortinet stands out as the cybersecurity stock with the best
![Fortinet Positioned For Growth In AI-Based Cybersecurity Boom: https://www.valuewalk.com/wp-content/uploads/2023/05/Cyber-Insurance-300x150.jpeg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekVSYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3d00e9a4f8aa52a356ad62f43ff8ca7aa24877d7/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Cyber-Insurance-300x150.jpeg?locale=us)
Fortinet Positioned For Growth In AI-Based Cybersecurity Boom
Key Points
- Cybersecurity spending on enterprise information security is projected to grow rapidly, driven by factors such as AI.
- Fortinet stands out as the cybersecurity stock with the best
![Zenocutuzumab (Zeno) erhält zweiten Status als zukunftsweisende Therapie von der US-amerikanischen Food and Drug Administration](/assets/news/news2-a19c21d90ec8043c932052617f43da76ea8e48ecd096318e237ea24d69a5c8b8.png)
Zenocutuzumab (Zeno) erhält zweiten Status als zukunftsweisende Therapie von der US-amerikanischen Food and Drug Administration
– Zeno erhält Status als zukunftsweisende Therapie für die Behandlung von nicht-kleinzelligem NRG1+-Lungenkrebs
UTRECHT, Niederlande und CAMBRIDGE, Mass., July 06, 2023 (GLOBE NEWSWIRE) --
![The Top Stocks Sold by Institutional Investors: https://www.valuewalk.com/wp-content/uploads/2023/07/XOM_2023-07-05_20-38-45.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkZFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c0aed74d1eb7b796d466114048c73067ca33094e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/XOM_2023-07-05_20-38-45.jpg?locale=us)
The Top Stocks Sold by Institutional Investors
An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities. These are very big investors that make investments on behalf of
![The Top Stocks Sold by Institutional Investors: https://www.valuewalk.com/wp-content/uploads/2023/07/XOM_2023-07-05_20-38-45.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkZFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c0aed74d1eb7b796d466114048c73067ca33094e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/XOM_2023-07-05_20-38-45.jpg?locale=us)
The Top Stocks Sold by Institutional Investors
An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities. These are very big investors that make investments on behalf of
![The Top Stocks Sold by Institutional Investors: https://www.valuewalk.com/wp-content/uploads/2023/07/XOM_2023-07-05_20-38-45.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkZFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c0aed74d1eb7b796d466114048c73067ca33094e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/XOM_2023-07-05_20-38-45.jpg?locale=us)
The Top Stocks Sold by Institutional Investors
An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities. These are very big investors that make investments on behalf of
![The Top Stocks Sold by Institutional Investors: https://www.valuewalk.com/wp-content/uploads/2023/07/XOM_2023-07-05_20-38-45.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNkZFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--c0aed74d1eb7b796d466114048c73067ca33094e/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/XOM_2023-07-05_20-38-45.jpg?locale=us)
The Top Stocks Sold by Institutional Investors
An institutional investor is a legal entity that pools money from multiple investors to invest in various assets and securities. These are very big investors that make investments on behalf of
![Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud: https://www.marketbeat.com/logos/articles/med_20230702164345_chart-snow2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGxFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--100465a953b6c1c4fd847a23330099de02ac6304/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230702164345_chart-snow2.jpg?locale=us)
Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud
Cloud-based data warehouser Snowflake (NASDAQ: SNOW) stock has been forming a rounding bottom since its $119.26 low in January 2023. Snowflake’s platform enables many different workloads on a
![Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud: https://www.marketbeat.com/logos/articles/med_20230702164345_chart-snow2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGxFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--100465a953b6c1c4fd847a23330099de02ac6304/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230702164345_chart-snow2.jpg?locale=us)
Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud
Cloud-based data warehouser Snowflake (NASDAQ: SNOW) stock has been forming a rounding bottom since its $119.26 low in January 2023. Snowflake’s platform enables many different workloads on a
![Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud: https://www.marketbeat.com/logos/articles/med_20230702164345_chart-snow2.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeGxFYXc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--100465a953b6c1c4fd847a23330099de02ac6304/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/med_20230702164345_chart-snow2.jpg?locale=us)
Snowflake Partners with NVIDIA and Microsoft for AI Data Cloud
Cloud-based data warehouser Snowflake (NASDAQ: SNOW) stock has been forming a rounding bottom since its $119.26 low in January 2023. Snowflake’s platform enables many different workloads on a
![Zenocutuzumab (Zeno) erhält Status als zukunftsweisende Therapie für die Behandlung von NRG1+-Bauchspeicheldrüsenkrebs von der US-amerikanischen Food and Drug Administration](/assets/news/news1-f26f2455ece0c3cbea64441818e795358cadddddb27e796f883ae2bd06f66139.png)
Zenocutuzumab (Zeno) erhält Status als zukunftsweisende Therapie für die Behandlung von NRG1+-Bauchspeicheldrüsenkrebs von der US-amerikanischen Food and Drug Administration
UTRECHT, Niederlande und CAMBRIDGE, Mass., June 30, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein im klinischen Stadium tätiges Onkologieunternehmen, das innovative multispezifische